Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: j g cordes who wrote (27150)	1/5/1999 7:10:00 AM
From: Cheryl Galt	Read Replies (2) \| Respond to of 32384

Jim, I appreciate your gracious response to my post. Thank you for understanding my intentions. I have this dream that by the end of 1999 everyone on the thread will have learned to bat ideas around without batting each other around! Brainstorming is great fun if one doesn't have to wear protective armor! <G> By the way, the 4th archived Forbes article -- "Murphy's Law" -- was also interesting, and pertinent to the current discussion. It talks about the main holding in one of Murphy's three mutual funds -- called Murphy New World Tech Convertible Fund (MNWTX). Glycomed converts represent 26.4% of this fund's assets! No wonder he's enthusiastic about Ligand!! (... not to bash Ligand, but just to wonder if Murphy is capable of heroic objectivity ...) Someone should explain to Murphy about diversification, and biotech baskets .... <g> I wonder if his followers are aware of this heavy investment ... Look at it, and see if it hits you the same way it does me .... forbes.com Regards Cheryl